2015-2019 Italy Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

September 2015 | 570 pages | ID: 22C84EB1E7DEN
Venture Planning Group

Abstracts

Complete report $6,800. DataPack (test volumes, sales forecasts, supplier shares) $3,450. 2015-2019 Italy Cancer Diagnostics Market is a newstrategic analysis of the major business opportunities emerging in the cancer diagnostics market during the nextfive years. The report examines trends in the Italian cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers. RationaleThe cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion. Business Opportunities and Strategic Recommendations- Specific new product development opportunities with potentiallysignificant market appeal during the next five years. - Design criteria for new products. - Alternative market penetration strategies.

Potential market entry barriers and risks. Cancer Diagnostic Tests—Over 200 current and emerging assays including:ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27. 29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA,Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG, Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar, Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone, Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein, Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin, Tissue Polypeptide Antigen, and others. Market Segmentation Analysis- Sales and market shares of major suppliers, by individual cancer diagnostic test. - Five-year test volume and sales forecasts for major cancer diagnostic tests by market segment, including:- Hospitals- Commercial/Private Laboratories- Comprehensive market segmentation analysis, including reviewof the market dynamics, structure, size, growth and major suppliers. - Cancer statistics, etiology and recent developments. Current and Emerging Products- Review of over 200 current and emerging cancer diagnostic tests,including:- Biochemical Markers- Oncogenes- Growth Factors- Hormones- Colony Stimulating Factors- Lymphokines- Immunohistochemical Stains, and others. - Analysis of major immunoassay analyzers used forcancer diagnostic testing, including their operating characteristics,features and selling prices. Technology Review- Assessment of monoclonal antibodies, immunoassays, DNAprobes, biochips/microarrays, chromosome analysis, IT,artificial intelligence, flow cytometry, biosensors, and other technologies and their potential applications for cancer diagnostic testing. - Review of competing/complementing technologies, includingCT, MRI, NMR, PET and photonics spectroscopy. - Extensive listings of over 500 companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Assessments- Strategic assessments ofmajor suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborativearrangements, and new products in R&D. Contains 570 pages and 83 tables

Contents

I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Routine and Special Hematology Tests
  1. Introduction
  2. CBC Analysis
    a. Hemoglobin Concentration
    b. Hematocrit Determination
    c. Red Blood Cell Count
    d. Red Cell Indices
      MCV
      RDW
      MCHC
      CHCM
      HDW
      MCH
    e. Red Cell Size Histograms
    f. Platelets
      Platelet Count
      Platelet Size/MPV
      PDW
      Automated Systems
    g. Reticulocytes
  3. White Blood Cell Analysis
    a. WBC Count
    b. Five-Partial Differential Major Suppliers
      Abbott
Beckman Coulter/Danaher
      Siemens
      Sysmex
    c. Pattern Recognition Systems
      IRIS
    d. Comparison of Major Differential Analyzers
  4. Reticulocytes
  5. Platelet Function Tests
  6. Erythrocyte Sedimentation Rate/CRP
  7. Red Cell Analysis
  8. 2, 3 DPG
  9. Red Cell Deformability
  10. Neutrophil Function Tests
  11. Semen Analysis
  12. Bone Marrow Analysis
  13. Urinalysis
B. Major Flow Cytometry Applications
  1. Cell Surface Markers
    a. Lymphocyte Subclassification CD4/CD8
      Instrumentation and Reagent Test Kits
        BD
  Beckman Coulter/Danaher
        T Cells Diagnostics
    b. Other Cell Markers
  2. DNA Content Analysis
  3. RNA Content Analysis
  4. Chemotherapy Monitoring
  5. Cell Cycle Analysis
  6. Chromosome Analysis
  7. Fetal Cell Analysis
  8. HLA Typing
  9. Microbiology
  10. Protein Content Analysis
  11. Multiparameter Analysis
  12. Other Applications
C. Instrumentation Review
  1. Hematology Analyzers
    a. Overview
      Electrical Aperture-Impedance Analyzers
      Light Scatter Analyzers
    b. System Review
      Abbott
Beckman Coulter/Danaher
      Biocode Hycel
      CellaVision
      Drew-Scientific
      Horiba
      Medica
      Menarini
      Nihon Kohden
      Siemens
      Sysmex
  2. Flow Cytometers
    a. Introduction
    b. System Overview
Becton Dickinson
Beckman Coulter/Danaher
  3. Platelet Aggregometers
  4. Sedimentation Rate Analyzers
      Diesse Ves Matic
Polymedco
D. Current Market Needs and Future Demand For Hematology Analyzers
E. Reagents and Controls
F. Current and Emerging Technologies
  1. Information Technologies
  2. Automation and Robotics
  3. Lasers
  4. Artificial Intelligence
  5. Monoclonal Antibodies
  6. Molecular Diagnostics
  7. Microdrop Technology

III. SPAIN

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Instrument Placements, Installed Base, Sales and Market Shares

X. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products

XI. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

XII. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized Testing Markets
  1. Four Marketing Approaches
  2. Product Complexity Factor
  3. Customer Preference Factor
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation Factor

XIII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XIV. COMPETITIVE ASSESSMENTS

Abbott
Agilent Technologies
Beckman Coulter/Danaher
Becton Dickinson
Bio-Rad
CellaVision
Horiba
Iris Diagnostics/Danaer
Nihon Kohden
Ortho-Clinical Diagnostics
Roche
Siemens
Sysmex

XV. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING HEMATOLOGY/FLOW CYTOMETRY TECHNOLOGIES AND APPLICATIONS

List Of Tables

LIST OF TABLES

Summary Table I: Spain, Total Hematology and Flow Cytometry Specimen Volume Forecast
Summary Table II: Spain, Total Hematology And Flow Cytometry Test Volume Forecast
Summary Table III: Spain, Total Hematology And Flow Cytometry Market Forecast
Spain, Hospital Laboratories Performing Hematology/Flow Cytometry Tests By Bed Size
Spain, Hospital Laboratories, Hematology And Flow Cytometry Specimen Volume Forecast
Spain, Hospital Laboratories, Routine Hematology Test Volume Forecast
Spain, Hospital Laboratories, Flow Cytometry and Special Hematology Test Volume Forecast
Spain, Major Hematology Analyzers, Estimated Placements And Installed Base
Spain, Major Flow Cytometers, Estimated Placements And Installed Base
Spain, Total Hematology Diagnostics Market By Major Supplier
Spain, Hematology Instrument Market By Major Supplier
Spain, Hematology Consumable Market By Major Supplier
Spain, Total Flow Cytometry Market By Major Supplier
Spain, Total Flow Cytometry Consumables Market By Major Supplier
Spain, Total Flow Cytometry Instrument Market By Major Supplier